TrueDx was built on a simple observation: the pathologists who read a specimen the first time are rarely wrong — but they're also rarely subspecialists in that exact tissue type, and they're human. We make the same second-look standard used at major cancer centers available to anyone, before treatment starts.
A second opinion that only re-reads the original paperwork isn't independent. Every TrueDx case starts with the physical slides, blocks, or a full-resolution digital scan.
A general pathologist and a breast subspecialist can look at the same slide and reach different conclusions. We route by organ system, not by whoever is next in the queue.
Our report is a second data point for the conversation you have with your treating physician — never a diagnosis delivered in place of your care team.
TrueDx is being built around clinical rigor, clear communication, and patient-centered operations.
TrueDx started as a way for patients to get an independent pathology read before a major treatment decision. That work depends entirely on having enough board-certified subspecialists available to take cases quickly.
That's why we're also building a network where licensed pathologists can pick up second-opinion cases on their own schedule — matched strictly to their license state and subspecialty, credentialed once, and paid per case.
A flexible, carefully credentialed pathologist network is central to making specialist review more accessible.
Reach us directly — a person reads every message.